Successful aging: Definition, prevention and treatment;Vieillissement réussi: Définitions, stratégies préventives et thérapeutiques

Medecine Therapeutique

Volumn 13, Issue 1, 2007, Pages 3-16

  Le Deun, Paule ^a   Gentric, Armelle ^b  

^a Groupe Hospitalier St Augustin Malestroit   (Germany)

^b BREST UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MELATONIN; MEVINOLIN; PRASTERONE; PRAVASTATIN; RETINOL; SELENIUM; SIMVASTATIN; ZINC;

ANDROGEN THERAPY; CARDIOVASCULAR DISEASE; COGNITION; DEMOGRAPHY; HUMAN; HYPERCHOLESTEROLEMIA; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MEDICAL ETHICS; PATHOGENICITY; PATIENT SATISFACTION; PERSONALITY; PREVENTIVE MEDICINE; QUALITY OF LIFE; REVIEW; SOCIAL STATUS; VITAMIN SUPPLEMENTATION;

EID: 34447291887     PISSN: 12646520     EISSN: None     Source Type: Journal    
DOI: 10.1684/met.2007.0048     Document Type: Review

References (85)

1. Phelan EA, Larson EB. Successful Aging - where next? JAGS 2002 ; 50 : 1306-8.
2. Manton KG, Gu X. Changes in the prevalence of chronic disability in the United States black and non black population above age 65 from 1982 to 1999. Proct Natl Acad Sci USA 2001 ; 98 : 6354-9.
3. Federal interagency forum on Aging related statistics. Older Americans 2000: Key indicators of well being. Hyattsville, MD : National Center for health statistics, 2000.
4. Insee. Chiffres clefs de la population française entre 1950 et 2000.
5. OMS. Données OMS sur la santé dans le monde.
6. Rowe JW, Kahn RL. Successful aging. Aging 1998 ; 10(2) : 142-4.
7. Jeandel. Le vieillissement réussi : plus qu'un paradigme, un objectif à atteindre. In : Vieillir au XXIe siècle, une nouvelle donne. Editions Universalis, collection Le Tour du sujet, 192 pages.
8. Lupien SJ, Wan N. Successful aging : from cell to self. Philos Trans R Soc Lond B Biol Sci 2004 ; 359(1449) : 1413-26.
9. Havighurst RJ, Albrecht R. Older People. NY : Longmans, 1953.
10. Palmore E. Predictors of successful aging. Gerontologist 1979 ; 19 : 427-31.
11. Perls TT, Silver MH. Living to 100. Lessons in Living to your maximal potential at any age. NY : Basic Books, 1999.
12. Roos NP, Havens B. Predictors of successful aging : A twelve-year study of manitob elderly. Am J Public Health 1991 ; 81 : 63-8.
13. Rowe JW, Kahn RL. The future of aging. Contemp Longterm Care 1999 ; 22(2) : 36-42.
14. Baltes PB, Smith J. New frontiers in the future of aging: from successful aging of the young old to the dilemmas of the fourth age. Gerontology 2003 ; 49(2) : 123-35.
15. Wiliams RH, Withs CG. Lives through the years : Styles of Life and successful aging. New York : Atherton press, 1965.
16. Strawbridge W, Wahlhagen M. Self rated successful aging: correlates and predictors. New York : Springer, 2003.
17. Butt DS, Beiser M. Successful aging: A theme for international psychology. Psychol Aging 1987 ; 2 : 87-94.
18. Ryff CD. Successful aging: A developmental approach. Gerontologist 1982 ; 22 : 209-14.
19. Schulz R, Heckhausen J. A life span model of successful aging. Am Psychol 1996 ; 51 : 702-14.
20. Gowe AJ, Whiteman MC, Pattie A, Whalley L, Starr J, Deary IA. Lifetime intellectual function and satisfaction with life in old age. BMJ 2005 ; 331 : 141-2.
21. Fisher BJ. Successful aging, life satisfaction, and generativity in later life. Int J Aging Dev 1995 ; 41(3) : 239-50.
22. Baltes PB, Baltes MM, eds. Successful aging. Perspectives from the behavioural sciences. Cambridge : New York, 1990.
23. Meire P. La vulnérabilité des personnes âgées. Louvain med 2000 ; 119 : S221-S226.
24. Mangham C, McGrath P, Reid G, Stewar M. Resilience, pertinence dans le contexte de la promotion de la santé. Atlantic Health Promotion Research Centre, Université Dalhousie. Document de travail - Analyse détaillée présentée en 1995 à Santé Canada.
25. Chiriboga DA, Jenkins G, Bayley J. Stress and coping among hospice nurses: test of an nalvtic model. Nurs Res 1983 ; 32(5) : 294-9.
26. Meeks S, Murrel SA. Contribution of education to health and life satisfaction in older adults mediated by negative affect. J Aging Health 2001 ; 13(1) : 92-119.
27. Richaud de Minzi MC, Sacchi G. Stressful situations and coping strategies in relation to age. Psychol Rep 2005 ; 97(2) : 405-18.
28. Deimling GT, Wagner LJ, Bowman KF, Sterns S, Kercher K, Kahana B. Coping among older-adult, long-term cancer survivors. Psychooncology 2005.
29. Smith J, Baltes PB. Wisdom related kowledge: Age cohort differences in response to life-planning problems. Dew psychol 1990 ; 26 : 495-505.
30. Rowe JW, Kahn RL. Successful aging and disease prevention. Adv Ren Replace Ther 2000 ; 7(1) : 70-7.
31. Mc Ewen BS. Stressed or stressed out: what is the difference? Rev Psychiatr Neurosci 2005 ; 30 : 315-8.
32. Mac Ewen BS. Protective and damaging effects of stress mediators. N Engl J Med 1998 ; 338 : 171-9.
33. Seeman TE, Crimmins E, Huang MH, et al. Cumulative biological risk and socioeconomic differences in mortality: mac Arthur Studies of Successful Aging. Soc Sc med 2004 ; 58 : 1985-97.
34. Seemann TE, McEwen BS, Rowe JW. Allostatic load as a marker of cumulative biological risk: mac Arthur studies of successful aging. Proc Natl Acad Sci U S A 2001 ; 98(8) : 4770-5 ; (April 10).
35. Tabbarah M, Crimmins EM, Seeman TE. The relation ship between coginitive and physical performance: Mac Arthur Studies of successful. Aging. J Gerontol A Biol Sci Med Sci 2002 ; 57(4) : 228-35.
36. Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 2000 ; 57(10) : 925-35.
37. Sapolsky RM. Stress hormones: good and bad. Neurobiol Dis 2000 ; 7(5) : 540-2.
38. Burnet FM, Holmes MC. Immunological function of thymus and bursa of Fabricius. Thymus lesions in an auto-immune disease of mice. Nature 1964 ; 194 : 146-7.
39. Kirkwood TB. Genes that shape the course of ageing. Trends Endocrinol Metab 2003 ; 14(8) : 345-7.
40. Cutler RG. Oxidative stress profiling: part and. its potential importance in the optimization of humanhealth. Ann N Y Acad Sci 2005 ; 1055 : 93-135.
41. Hirsch EC. Radicaux libres. Neurol 1993 ; 33 : 52-9.
42. Groupe d'étude canadien sur l'examen médical périodique. Dans : Guide canadien de médecine clinique préventive. Ottawa : Santé Canada ; 1994. Site Internet : www.hsc.gc.ca/hppb/soinsdesanté/pubs/clinique/index.html.
43. Champoux N. Les secrets révélés du vieillissement réussi. Le médecin du Québec 2005 ; 40 : 77-81.
44. Durieux P. Les recommandations pour la pratique clinique. In : L'évaluation médicale : du concept à la pratique. Paris : Flammarion Médecine Sciences, 1994.
45. Triscott JAC, Handfield-Jones RS, Bell-Irving KA, et al. Evidence-based care of the elderly health-guide. Geriatrics Today 2002 ; 6 : 36-42.
46. Mehr DR, Tatum PE. Primary prevention of diseases of old age. Clin Geriatr Med 2002 ; 18(3) : 407-30.
47. Buchner DM, Wagner EH. Preventing frail health. Clin Geriatr Med 1992 ; 8(1) : 1-17.
48. Aquino JP, Martino S. La prévention en gerontology. PNPV 2003 ; 1 : 37-43.
49. Heart Outcome Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000 ; 355 : 253-9.
50. HOPE Study Investigators. The HOPE (Heart Outcomes Prevention Evaluations) Study: the design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. Can J Cardiol 1996 ; 12 : 127.
51. Premiers résultats de l'étude SUVIMAX. www.bconcept.net/ suvimax.html.
52. Heart Protection Study Collaborative Group. Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo controlled trial. Lancet 2002 ; 360 : 7-22.
53. Scandinavian Simvastatin Survival Study. Lancet 1994 ; 344 : 1383-9.
54. Strandberg TE, Pyorala K, Cook TJ, et al. Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S). Lancet 2004 ; 364(9436) : 771-7.
55. Cholesterol And Recurrents Events. N Engl J Med 1995 ; 333 : 1301-7.
56. Long Term Intervention With Pravastatin in Ischaemic Disease. JAMA 1985 ; 253 : 2080-6.
57. West of Scotland Coronary Prevention Study. N Engl J Med 1996 ; 335 : 1001-9.
58. Clearfield M, Downs JR, Weis S, et al. Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): efficacy and tolerability of long-term treatment with lovastatin in women. J Womens Health Gend Based Med 2001 ; 10(10) : 971-81.
59. Writing group for the Women's Health Initiative investigators. Risks and benefits of estrogen plus progestin in healthy post menopausal women. JAMA 2002 ; 288 : 321-33.
60. Breast cancer and hormone-replacement therapy in the Million Women Study (MWS). Lancet 2003 ; 362 : 419-27.
61. Afssaps. Communiqué. Traitement hormonal substitutif et risque de cancer du sein (08/08/03).
62. Afssaps. Mise au point actualisée sur le traitement hormonal substitutif de la ménopause (THS). Décembre 2003.
63. Anaes/Afssaps. Rapport d'orientation sur les traitements hormonaux substitutifs de la ménopause Anaes/Afssaps, 11 mai 2004.
64. Afssaps. Rapport. Données françaises sur le traitement hormonal substitutif de la ménopause (THS) (13/10/05).
65. Afssaps. Communiqué. Traitement hormonal substitutif: nouvelles données de l'étude Million Women Study (MWS) (02/05/05).
66. Afssaps. Rapport Traitement hormonal substitutif de la ménopause - Caractéristiques de l'utilisation en France - Effets sur la survenue de cancers du sein et d'évènements cardiovasculaires en France - Propositions d'études complémentaires. 13/10/2005.
67. Fournier A, et al. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. Int J Cancer 2005 ; 114(3) : 448-54.
68. Afssaps. Communqué. Traitement hormonal substitutif (THS). Risque de démence et troubles des fonctions cognitives (27/05/03).
69. Shumaker, et al. Oestrogen plus Progestin and the incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women: The Women's Health Initiative Memory Study - (WHIMS). JAMA 2003 ; May.
70. Baulieu EE, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: Contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci USA 2000 ; 97 : 4279-84.
71. Huppert FA, et al. Dehydroepiandrosterone (DHEA) supplementation for cognition and well being. Cochrane Database of Systematic Reviews. The Cochrane Library, 2001.
72. Bambart KT, et al. Rapport DHEA. J Clin Endoc Metab 1999.
73. Casson PR, et al. Postmenopausal dehydroepiandrosterone administration increase free insulin-like growth factor-I and decrease high-density lipoprotein: a six-month trial. Fertil Steril 1998 ; 70 : 107-10.
74. Afssaps. Rapport sur la DHEA. Groupe ad hoc. 3 juillet 2001.
75. Lejeune H. Déficit androgénique lié à l'âge. Androl 2001 ; 11(4) : 231-9.
76. Morales A, Lunenfeld B. Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging Male. Aging Male 2002 ; 5 : 74-86.
77. Cuzin B, Giuliano F, Jamin C, et al. Diagnostic, traitement et surveillance de l'hypogonadisme de survenue tardive chez l'homme. Recommandations officielles de l'International Society for the Study of the Aging Male (ISSAM) et commentaires. Ann Endocrinol (Paris) 2003 ; 64 : 289-304.
78. Rossi D, Tostani J. Recommandations pour la prise en charge du déficit androgénique lié à l'âge. Prog Urol 2004 ; 14 : 859-65.
79. Chatelain P, De Parscau L, Nicolino M. Hormone de croissance biosynthétique ; actualités et perspectives thérapeutiques. Pediatric 1989 ; 44 : 175-82.
80. Bella LD, Gualano L. Key aspects of melatonin physiology: Thirty years of research. Neuroendocrinol Lett 2006 ; 27 : 4.
81. Sethumadhavan S, Chinnakannu P. L-Carnitine and {alpha}-Lipoic Acid Improve Age-Associated Decline in Mitochondrial Respiratory Chain Activity of Rat Heart Muscle. J Gerontol A Biol Sci Med Sci 2006 ; 61(7) : 650-9.
82. Sethhumadhavan S, Chinnakanum P. Carnitine and lipoic Acid alleviates protein oxidation in heart mitochondria during aging process. Biogerontology 2006 ; 7(2) : 101-9.
83. Mansour HH. Protective role of carnitine ester against radiation-induced oxidative stress in rats. Pharmacol Res 2006 ; 54(3) : 165-71.
84. Arivazhagan P, Ayusawa D, Panneerselvam C. Protective efficacy of alpha-lipoic acid on acetylcholinesterase activity in aged rat brain regions. Rejuvenation Res 2006 ; 9(2) : 198-201.
85. Shimbun A. Okinawa, l'île des centenaires. Courrier international 2002 ; 604 : 1-3.